Cargando…
PLP2 Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme
OBJECTIVE: This study aimed to discern the association between PLP2 expression, its biological significance, and the extent of immune infiltration in human GBM. METHODS: Utilizing the GEPIA2 and TCGA databases, we contrasted the expression levels of PLP2 in GBM against normal tissue. We utilized GEP...
Autores principales: | Qiao, Hao, Li, Huanting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642424/ https://www.ncbi.nlm.nih.gov/pubmed/37964785 http://dx.doi.org/10.2147/PGPM.S425251 |
Ejemplares similares
-
Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme
por: Liu, Erheng, et al.
Publicado: (2023) -
TSPAN4 is a prognostic and immune target in Glioblastoma multiforme
por: Zheng, Yue, et al.
Publicado: (2023) -
Biomarkers for glioblastoma multiforme: status quo
por: Montano, Nicola, et al.
Publicado: (2016) -
Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017) -
Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme
por: Li, Hao, et al.
Publicado: (2021)